INNATE PHARMA (EPA:IPH) Innate Pharma SA, a biopharmaceutical company developing first-in-class drug candidates targeting the innate immune system, today announces an operating revenue of 12.9 million Euros for the year 2008.
Transparency directive : regulatory news
06/02/2009 17:30
source : webdisclosure.com